Welcome to DIA (original) (raw)
Six Decades of Impact: Our Global Journey
Together We Accelerate Global Health Innovation for All
×
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Integrating Patient Expertise into Product Innovation and Development
Engaging patients early in development provides real-world experiences, unmet needs, and preferences not found in textbooks or databases.
Global CTD and Data Transparency Conference
Enhance trial transparency, navigate regulatory changes, and explore AI-driven practices while expanding your network across other clinical and regulatory life science professionals.
Podcast
DIA: Going Beyond the Traditional Definition of Drug Development
In this DIA 60th anniversary interview, former Board President Ling Su shares the two most important aspects of DIA’s future for the next generation of members.
Explore Areas of Interest
Global Forum, DIA's Digital Magazine
Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.
Member Spotlight
people_outline Member Spotlight
Learn More
Casey Walker
“There were a few of her patients who were victims of substance abuse, and seeing how my aunt provided care for them inspired me to discover methods to treat victims such as these with a career in pharmacy.”
Doctor of Pharmacy Candidate, Howard University
people_outline Member Spotlight
Learn More
Jingsong Wang
“We still have a lot of unmet medical and patient needs that can only be addressed when the community (including researchers, physicians, and policymakers) decide to work together. This is happening more and more in recent years, the outcomes of which you see in some of the most advanced medicines and healthcare systems available today.”
CEO, Harbour BioMed
people_outline Member Spotlight
Learn More
Kim Quaintance-Lunn
“The greatest challenge in my view is the lack of harmonization among global health authorities. I will moderate that statement by saying that we should not harmonize for the sake of harmonization. We should harmonize to the best practice.”
Vice President and Head, Regulatory Policy, North American Regulatory Affairs, Bayer
people_outline
“There were a few of her patients who were victims of substance abuse, and seeing how my aunt provided care for them inspired me to discover methods to treat victims such as these with a career in pharmacy.”